MINNEAPOLIS, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its participation in the Stifel 2025 Healthcare Conference to be held in New York on November 11-13, 2025.
Celcuity To Present at Upcoming Stifel 2025 Healthcare Conference
Seeking Alpha / 1 hour from now 1 Views
Comments